Leyla Yurttas

Prof. Dr. Leyla Yurttas

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SDSeref Demirayak
Seref Demirayak
IKIsmail Kayagil
Ismail Kayagil
Leyla YurttasLeyla Yurttas
Leyla Yurttas

1 January 2022 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Asaf Evrim EVRENAsaf Evrim EVREN
Asaf Evrim EVREN
DNDemokrat Nuha
Demokrat Nuha
SDSam Dawbaa
Sam Dawbaa
BSBegüm Nurpelin Sağlık
Begüm Nurpelin Sağlık
Leyla YurttasLeyla Yurttas
Leyla Yurttas

31 May 2012 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Closed access
Leyla YurttasLeyla Yurttas
Leyla Yurttas
YÖYusuf Özkay
Yusuf Özkay
ZKZafer Asım Kaplancıklı
Zafer Asım Kaplancıklı
YTYağmur Tunalı
Yağmur Tunalı
HKHülya Karaca
Hülya Karaca
In this work, we synthesized fourteen different compounds which contain hydrazone bridged thiazole and pyrrole rings. For this purpose, pyrrole-2-carboxaldehydes were reacted directly with thiosemicarbazide in ethanol and then obtained thiosemicarbazones were condensed with α-bromoacetophenone derivatives (Hantzsch reaction) to give 1-substituted pyrrole-2-carboxaldehyde [4-(4-substituted phenyl)-1,3-thiazol-2-yl] hydrazones. The structures of the obtained compounds were elucidated by using IR, 1H-NMR and FAB+-MS spectral data and elemental analyses results. All of the compounds were screened for their antibacterial and antifungal activities against twelve different microorganisms by using microbroth dilution method. Ketoconazole and chloramphenicol were used as standard drugs. All of the compounds showed good activity against Staphylococcus aureus and Enterococcus faecalis.

13 December 2023 in ACS Omega
Verified
Journal Article
Open access
Leyla YurttasLeyla Yurttas
Leyla Yurttas
Asaf Evrim EVRENAsaf Evrim EVREN
Asaf Evrim EVREN
AKAslıhan Kubilay
Aslıhan Kubilay
MAMehmet Onur Aksoy
Mehmet Onur Aksoy
HTHalide Edip Temel
Halide Edip Temel
GÇGülşen Akalın Çiftçi
Gülşen Akalın Çiftçi
In this work, some new 2-[(5-((2-acetamidophenoxy)methyl)-1,3,4-oxadiazol-2-yl)thio]acetamide derivatives (4a-4l) were synthesized and studied for their anticancer activity. Twelve new compounds were tested on the A549 human lung cancer cell line, C6 rat glioma cell line, and L929 murine fibroblast cell line. Compounds 4f, 4i, 4k, and 4l (IC50: 1.59-7.48 μM), and especially 4h (IC50: <0.14 μM), exhibited excellent cytotoxic profile on A549 with selectivity. Compounds 4g and 4h showed remarkable antiproliferative activity on the C6 cell line with IC50 values of 8.16 and 13.04 μM, respectively. The compounds with the lowest IC50 value on the A549 cell line (4f, 4h, 4i, 4k, and 4l) were further studied to determine the mechanism of action. These compounds were found to induce apoptosis with a higher ratio (16.10-21.54%) than that of the standard drug cisplatin (10.07%). Compound 4f displayed mitochondrial membrane depolarization and caspase-3 activation at most, whereas compounds 4h (89.66%) and 4i (78.78%) had outstanding retention rates in the G0/G1phase of the cell cycle (cisplatin 74.75%). Compounds 4f, 4g, 4h, and 4l exhibited matrix metalloproteinase-9 (MMP-9) inhibition higher than 75% at 100 μg/mL; even IC50 values were found to be 1.65 and 2.55 μM for 4h and 4l. In addition, in silico physicochemical properties of the compounds and molecular docking interaction of compound 4h on the MMP-9 enzyme were evaluated; the desired and expected results were obtained.

1 November 2014 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
Leyla YurttasLeyla Yurttas
Leyla Yurttas
ŞDŞeref Demirayak
Şeref Demirayak
SISinem Ilgın
Sinem Ilgın
ÖAÖzlem Atlı
Özlem Atlı

7 February 2013 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
Leyla YurttasLeyla Yurttas
Leyla Yurttas
YÖYusuf Özkay
Yusuf Özkay
GAGülşen Akalın-Çiftçi
Gülşen Akalın-Çiftçi
ŞUŞafak Ulusoylar-Yıldırım
Şafak Ulusoylar-Yıldırım
A new class of novel thiazole-(benz)azole derivatives was synthesized to investigate their anticancer activity. The structure of the compounds was confirmed by IR, 1H-NMR, and MS spectral data and elemental analyses. Anticancer effect of the compounds was evaluated against A549 and C6 tumor cell lines. MTT, analysis of DNA synthesis, acridine orange/ethidium bromide staining method and analysis of caspase-3 activation assays were performed for anticancer activity investigations. Compounds 6f and 6g, which carry 5-chloro and 5-methylbenzimidazole groups showed significant anticancer activity. Potential of these compounds to direct tumor cells to apoptotic pathway, which is a precondition of anticancer action, was also observed.